In vitro antigenotoxicity of Ulva rigida C. Agardh (Chlorophyceae) extract against induction of chromosome aberration, sister chromatid exchange and micronuclei by mutagenic agent MMC

Biomedical and Environmental Sciences

Volumn 21, Issue 6, 2008, Pages 492-498

  Celikler, Serap ^a   Yildiz, Gamze ^a   Vatan, Ozgur ^a   Bilaloglu, Rahmi ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Anticlastogenicity; Antigenotoxicity; Chromosomal aberration; Micronuclei; Mitomycin C; Sister chromatid exchange; Ulva rigida

Indexed keywords

CHLOROPHYCEAE; ULVA; ULVA RIGIDA;

EID: 59849096093     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-3988(09)60008-8     Document Type: Article

References (40)

1. Michanek G (1979). Seaweed resources for pharmaceutical uses. In: Hoppe H A, Levring T, Tanaka Y, and de Gruyter W (Eds.). Marine algae in pharmaceutical science (pp. 203-234). New York: Berlin.
2. Fujimot K, Ohmura H, Kaneda T (1985). Screening antioxygenic compounds in marine algae and bromophenols as effective principles in a red alga Polysiphonia urceolata. Bull Jpn Soc Sci Fish 51, 1139-1143.
3. Potterat O (1997). Antioxidants and free radical scavengers of natural origin. Curr Org Chem 1, 415-440.
4. Kloareg B, Quatrano R S (1988). Structure of the cell walls of marine algae and ecophysiological function of the matrix polysaccharides. Oceanogr. Mar Biol Annu Rev 26, 259-315.
5. Lindequist U, Schweder T (2001). Marine biotechnology. In: Rehm H J, Reed G (Eds.) Biotechnology 10, Wiley-VCH, Weinheim, 441-484.
6. Mayer A M S, Hamann M T (2002). Marine pharmacology in 1999: compounds with antibacterial, anticoagulant, antifungal, anthelmintic, anti-inflammatory, antiplatelet, antiprptozoal and antiviral activities affecting the cardiovascular, endocrine, immune and nervous systems, and other miscellaneous mechanisms of action. Comp Biochem and Physiol Part C 132, 315-319.
7. Newmann D J, Cragg G M, Snader K M (2003). Natrural products as source of new drugs over the period 1981-2002. J Nat Prod 66, 1022-1037.
8. Faulkner D J (2000a). Highlights of marine natural products chemistry (1972-1999). Natural Product Reports 17, 1-6.
9. Faulkner D J (2000b). Marine pharmacology. Antonie Van Leeuwenhoek 77(2), 35-145.
10. Witvrouw M, De Clercq E (1997). Sulfated polysaccharides extracted from sea algae as potential antiviral drugs. Gen Pharmac 29/4, 497-511.
11. Vairappan C S (2003). Potent antibacterial activity of halogenated metabolites from Malaysian red algae, Laurencia majuscule (Rhodomelaceae, Ceramiales). Biomol Eng 20, 255-259.
12. Ely R, Supriya T, Naik C G (2004). Antimicrobial activity of marine organisms collected off the coast of South East India. J Exp Marine Biol and Ecol 309, 121-127.
13. Bansemir A, Blume M, Schröder S, Lindequist U (2006). Screening of cultivated seaweeds for antibacterial activity against fish pathogenic bacteria. Aquaculture 252, 79-84.
14. Furusawa E, Furusawa S (1985). Anticancer activity of a natural product, viva-natural, extracted from Undaria pinnantifida on intraperitoneally implanted Lewis lung carcinoma. Oncology 42, 364-369.
15. Wu L C, Ho J A, Shieh M C, et al (2005). Antioxidant and antiproliferative activities of Spirulina and Chlorella water extracts. J Agricul Food Chem 53, 4207-4212.
16. Deslandes E, Pondaven P, Auperin T, et al. (2000). Preliminary study of the in vitro antiproliferative effect of a hydroethanolic extract from the subtropical seaweed Turbinaria ornata (Turner J. Argadh) on a human non-small-cell bronchopulmonary carcinoma cell line (NSCLC-N6). J Appl Phycol 12, 257-262.
17. Byers T, Perry G (1992). Dietary carotenes, vitamin C and vitamin E as protective antioxidants in human cancers. Annu Rev Nutr 12, 139-159.
18. Qi H, Zhang Q, Zhao T, et al. (2006). In vitro antioxidant activity of acetylated and benzoylated derivatives of polysaccharide extracted from Ulva pertusa (Chlorophyta). Bioorganic and Medicin. Chem Letters 16, 2441-2445.
19. Jin D Q, Lim C S, Sung J Y, et al. (2006). Ulva conglobata, a marine alga, has neuroprotective and anti-inflammatory effects in murine hippocampal and microglial cells. Neuroscience Letters 402, 154-158.
20. Hellio C, Bourgougnon N, Le Gal Y (2000). Phenoloxidase (EC 1.14.18.1) from the byssus gland Mytilus edulis: purification, partial characterization and application for screening products with potential antifouling activities. Biofouling 16, 235-244.
21. Khan N H, nur-E Kamal M S A, Rahman M (1988). Antibacterial activity of Euphorbia thymifolia Linn. Indian J Med Res 87, 395-397.
22. Fenech M (2000). The in vitro micronucleus technique. Mutat Res 455, 81-95.
23. Benn P A, Perle M A (1992). Chromosome staining and banding techniques, in: D. E. Rooney, B.H. Czepulkowsky (Eds.), Human Cytogenetics: A practical Approach 1-II, 57-83, IRL press, Oxford.
24. Parry P, Wolff S (1974). Giemsa method for differential staining of sister chromatids, Nature 251, 156-158.
25. I P C S (1985). Guide to short term tests for detecting mutagenic and carcinogenic chemicals, World Health Organization, Geneva.
26. Carrano A V, Natarajan A T (1988). Considerations for population monitoring using cytogenetics techniques, ICPEMC Publication No. 14, International Commission for Protection Against environmental mutagens and carcinogens. Mutat Res 204, 379-406.
27. Bonassi S, Fenech M, Lando C, et al. (2001). Human micronucleus project: international database comparison for results with the cytokinesis block micronucleus assay in human lymphocytes: effect of laboratory protocol, scoring criteria, and host factors on the frequency of micronuclei. Environ Mol Mutagen 37, 31-45.
28. Manoharan K, Banerjee M R (1985). β-Carotene reduces sister chromatid exchange induce chemical carcinogens in mouse mammary cells in organ culture, Cell Biol lnt Rep 9, 783-789.
29. Waters M D, Brady A L, Stack H F, et al. (1990). Antimutagenic profiles for some model compounds. Mutat Re 238, 57-85.
30. Cragg G M, Newman D J, Weiss R B (1997). Coral reefs, forests and thermal vents: the worldwide exploration of nature for novel antitumor agents. Seminars in Oncology 24, 156-163.
31. Koyabagi S, Tanigawa N, Nakgawa H, et al. (2003). Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities. Biochem Pharmacol 65, 173-179.
32. Funahashi H, Imai T, Mase T, et al (2001) Seaweed prevents breast cancer? Jpn J Cancer Res 92(5), 483-487.
33. Poersch A, Dos Santos F V, Medeiros-Maciel M A, et al. (2007). Protective effect of DCTN (trans-dehydrocrotonin) against induction of micronuclei and apoptosis by different mutagenic agents in vitro. Mutat Res 629, 14-23.
34. Ishihara K, Murata M, Kaneniwa M, et al. (2000). Purification of stearidonic acid (18:4(n-3) and hexadecatetraenoic acid (16:4(n-3)) from algal fatty acid with lipase and medium pressure liquid chromatography. Biosci Biotechnol Biochem 64(11), 2454-2457.
35. Kolb N, Vallorani L, Milanovic N, et al. (2004). Evaluation of marine algae wakame (Undaria pinnatifida) and kombu (Laminaria digitata japonica) as food supplements. Food Technol Biotechnol 42, 57-61
36. Kim J M, Araki S, Kim D J, et al. (1998). Chemopreventive effects of carotenoids and curcumins on mouse colon carcinogenesis after 1, 2-dimethylhydrazine initiation. Carcinogenesis 19(1), 81-85.
37. Kotake-Nara E, Kushiro M, Zhang H, et al (2001). Carotenoids affect proliferation of human prostate cancer cells. J Nutr 131(12), 3303-3306.
38. Kikunaga S, Miyata Y, Ishibashi G, et al. (1999). The bioavailability of magnesium from Wakame (Undaria pinnatifida) and Hijiki (Hijikia fusiforme) and the effect of alginic acid on magnesium utilization of rats. Plant Foods Hum Nutr 53(3), 265-274.
39. Bartle W R, Madorin P, Ferland G (2001). Seaweed, vitamin K, and warfarin. Am J Health Syst Pharm 58(23), 2300.
40. Aaronson S (2000). Important Vegetable Supplements. Chapter C, Part II. Staple Foods: 231-249. In: The Cambridge World History of Food. Cambridge University Press.